| Stage | JCI | % of rev | LII | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.6B | 100.00% | $1.6B | 100.00% | JCI ×4.21 |
| Gross profit | $2.5B | 37.41% | $497M | 31.62% | JCI +5.8pp |
| Operating income | $987M | 14.92% | $312M | 19.85% | LII +4.9pp |
| Pre-tax income | $917M | 13.86% | $293M | 18.65% | LII +4.8pp |
| Net income | $752M | 11.37% | $221M | 14.07% | LII +2.7pp |
| Stage | JCI | LII | Gap · A − B |
|---|---|---|---|
| Revenue | $6.6B100.00% | $1.6B100.00% | JCI ×4.21 |
| Gross profit | 37.41%$2.5B | 31.62%$497M | JCI +5.8pp |
| Operating income | 14.92%$987M | 19.85%$312M | LII +4.9pp |
| Pre-tax income | 13.86%$917M | 18.65%$293M | LII +4.8pp |
| Net income |
| 11.37%$752M |
| 14.07%$221M |
| LII +2.7pp |